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Diabetes mellitus (DM) is a common condition, affecting an estimated 
15.5 million people in Africa. Importantly, the prevalence of DM 
across the continent is expected to double by 2045.[1] Since 2015, 
this condition has been ranked as the second most common cause 
of natural death in South Africa (SA), and its impact on healthcare 
provision is substantial.[2] Accurate assessment of prevalence is 
difficult owing to the high burden of undiagnosed DM (estimated 
at 69% in Africa) and the lack of large population studies.[1] In SA, 
the prevalence of DM is estimated to be between 5.4% and 9.2%.[1,3] 
There are limited data reporting the prevalence of DM in Western 
Cape Province, SA, and information with regard to elective surgical 
patients is minimal. Many studies have shown that DM, especially if 
poorly controlled, is associated with an increased risk of perioperative 
complications and mortality.[4-9] In SA, insulin-dependent surgical 
patients are twice as likely as non-diabetics to die in hospital.[10]
Objectives
The primary objective of this study was to establish the prevalence of 
DM in patients presenting for elective surgery over a 1-week period 
in six Western Cape hospitals. This included patients with a previous 
diagnosis of DM, and those with a new diagnosis based on screening 
capillary blood glucose (CBG) testing and a confirmatory elevated 
glycated haemoglobin (HbA1c) level. The secondary objectives were 
to assess: (i) the glycaemic control of known diabetics presenting for 
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Background. Diabetes mellitus (DM) is a common condition. The high burden of undiagnosed DM and a lack of large population studies 
make accurate prevalence estimations difficult, especially in the surgical environment. Furthermore, poorly controlled DM is associated 
with an increased risk of perioperative complications and mortality.
Objectives. The primary objective was to establish the prevalence of DM in elective adult non-cardiac, non-obstetric surgical patients in 
hospitals in Western Cape Province, South Africa. The secondary objectives were to assess the glycaemic control and compliance with 
treatment of known diabetics.
Methods. A 5-day multicentre, prospective observational study was performed at six government-funded hospitals in the Western Cape. 
Screening for DM was done using finger-prick capillary blood glucose (CBG) testing. Patients found to have a CBG ≥6.5 mmol/L had their 
glycated haemoglobin (HbA1c) level measured. DM was diagnosed based on the Society for Endocrinology, Metabolism and Diabetes of 
South Africa (SEMDSA) diagnostic criteria. Patients known to have DM had their HbA1c measured and completed a Morisky Medication 
Adherence Scale (MMAS-4) questionnaire to assess glycaemic control and compliance with treatment.
Results. Of the 379 participants, 61 were known diabetics (16.2%; 95% confidence interval (CI) 12.4 - 19.8). After exclusion of 8 patients 
with incomplete results, a new diagnosis of DM was made in 5/310 patients (1.6%; 95% CI 0.2 - 3.0). The overall prevalence of DM was 
17.8% (66/371; 95% CI 13.9 - 21.7). HbA1c results were available for 57 (93.4%) of the 61 known diabetics. Of these, 27 (47.4%; 95% 
CI 34.4 - 60.3) had an HbA1c level ≥8.5% and 14 (24.6%; 95% CI 13.4 - 35.8) had a level ≤7%. Based on positive responses to two or more 
questions on the MMAS-4 questionnaire, 12/60 participants (20.0%) were deemed non-compliant.
Conclusions. There is a low rate of undiagnosed DM in our elective surgical population, but in a high proportion of patients with DM the 
condition is poorly controlled. Poorly controlled DM is known to increase postoperative complications and is likely to increase the burden of 
perioperative care. Resources should be focused on improvement of long-term glycaemic control in patients presenting for elective surgery.
S Afr Med J 2019;109(10):801-806. https://doi.org/10.7196/SAMJ.2019.v109i10.13898
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surgery, using the HbA1c level; and (ii) compliance with treatment, 
with the Morisky Medication Adherence Scale (MMAS-4).[11]
Methods
Study approval was obtained from the University of Cape Town 
Faculty of Health Sciences Human Research Ethics Committee (ref. 
no. UCT HREC: 386/2017) and the Western Cape Department of 
Health, and institutional approval was provided by all participating 
centres (ref. no. NHRD:WC_201709_018). The study was registered 
on Clinicaltrials.gov (ref. no. NCT03318055). Written informed 
consent was provided by all participants prior to enrolment. The 
study is presented according to the Strengthening the Reporting of 
Observational Studies in Epidemiology (STROBE) guidelines.[12]
This was a multicentre, prospective observational study performed 
at six government-funded hospitals in the Western Cape: Groote 
Schuur, New Somerset, Paarl, Victoria, Mitchell’s Plain and George 
hospitals. A prestudy power calculation based on an expected 
prevalence of DM of 10%[10] and an estimated sample size of 500 
(expected number of elective surgical procedures in the participating 
hospitals) allowed for an estimate of the prevalence with a 95% 
confidence interval (CI) of ±2.65%, i.e. 7.35 - 12.65%. Convenience 
sampling was done during the daytime hours (07h00 - 19h00) of a 
calendar week (Monday 16 October - Friday 20 October 2017).
Exclusion criteria were patient refusal or inability to consent, 
emergency and cardiac surgery, and pregnant and paediatric 
(<18 years of age) patients. All participants were seen preoperatively 
by the anaesthesia medical staff, and after written consent had been 
obtained, demographic and baseline data were collected and recorded 
on the case report form (CRF) (available as a supplementary file at 
http://www.samj.org.za/public/sup/simons_13898.pdf).
The diagnosis of DM in our study was based on recommendations 
of the Society for Endocrinology, Metabolism and Diabetes of South 
Africa (SEMDSA),[13] which state that the diagnosis can be made as 
follows: in an asymptomatic patient when any one of the following 
tests, repeated on separate days within a 2-week period, is confirmed: 
(i) fasting plasma glucose ≥7.0 mmol/L; (ii) 2 hours post glucose load 
≥11.1 mmol/L; or (iii) HbA1c ≥6.5%. In the event that both a glucose-
based test and the HbA1c test are done, if both are ‘diagnostic’ for 
diabetes, the diagnosis is confirmed.
HbA1c was measured in known diabetics who had not had a test 
result within the preceding 90 days. Screening for DM was done using 
finger-prick CBG testing in all consenting participants undergoing 
elective surgery. The mandatory starvation period of at least 6 hours 
for elective surgical patients was used as the fasting period for the 
fasting glucose measurement. Based on the recommended correction 
of CBG to reflect true plasma glucose (plasma glucose (mmol/L) = 
0.102 + 1.066 × CBG),[13] a capillary glucose level of ≥6.5 mmol/L 
was taken as a cut-off to reflect a plasma level ≥7.0 mmol/L. Patients 
found to have a CBG of ≥6.5 mmol/L had an HbA1c test to confirm 
the diagnosis of diabetes.
HbA1c results were linked via a unique CRF-generated laboratory 
number. Data were recorded on paper CRFs, and captured 
electronically onto the Research Electronic Data Capture (REDCap) 
application. Access to REDCap was protected by username and 
password. Patient confidentiality and anonymity were protected 
through unique numerical code generation during electronic data 
capturing. Patients identified as having raised fasting CBG were 
given referral letters to their primary healthcare facilities for further 
investigations and management.
SEMDSA advocates aiming for an HbA1c level of ≤7% in most 
patients (well-controlled DM). An HbA1c level of 7.1 - 8.5% is 
considered to indicate moderate control and may be acceptable in 
the following patient categories: elderly, frail, limited life expectancy, 
multiple comorbidities, severe vascular disease, advanced chronic 
kidney disease, recurrent severe hypoglycaemia, or unawareness of 
hypoglycaemia.[13] An HbA1c level of ≥8.5% is considered to indicate 
poor control. Compliance with treatment was assessed using the 
MMAS-4 score.[11] Non-compliance was taken as a positive response 
to two or more of the four questions in the MMAS-4.
Statistical analysis
Continuous variables with normal distribution were described as 
means and standard deviations (SDs). Between-group comparisons 
were performed using Fisher’s exact test, except for age (t-test) and in 
contingency tables that were more than 2 × 2 comparisons (American 
Society of Anesthesiologists (ASA) classification and functional status), 
where Pearson’s χ2 test was used. The Statistical Package for the Social 
Sciences (SPSS) version 24 (SPSS Inc., USA) was used for data analysis.
Results
The study flow diagram is shown in Fig. 1, and the breakdown of 
the contribution to final participant numbers from each hospital in 
Table 1. Participants known to have DM comprised 16.1% (61/379; 
95% CI 12.4 - 19.8) of the study population. Of the 318 participants 
who had not previously been diagnosed with DM, 310 (97.5%) 
had CBG and, where appropriate, HbA1c results available. A new 
diagnosis of DM was made in an additional 1.6% (5/310; 95% CI 0.2 - 
3.0) of participants not previously known to have DM. The overall 
prevalence of DM was therefore 17.8% (66/371; 95% CI 13.9 - 21.7). 
Of the 66 diabetic patients, 7.5% (5/66; 95% CI 1.2 - 13.9) were 
diagnosed during the study.
The demographic details of the study population are shown in 
Table 2. Univariate analysis showed an association between DM 
and increasing age, increasing ASA physical status classification, 
decreasing functional status and comorbidities. Based on positive 
responses to two or more questions on the MMAS-4 questionnaire, 
12/60 participants (20.0%) were non-compliant with therapy for DM.
Discussion
Principal findings
In our study population, one in six participants presenting for surgery 
was diabetic. Of the participants with DM, 92.5% were known 
diabetics prior to surgery, but almost half had poor glycaemic control 
as reflected by an HbA1c level ≥8.5% (Table 3).
The strength of this investigation was that it was a multicentre, 
prospective study that involved several regions in the Western 
Cape, SA. The research provided the most comprehensive data 
to date of the prevalence of diabetes in this elective adult surgical 
patient population, and therefore has implications for determining 
appropriate management plans for this population. In comparison 
with some previous prevalence studies, the study did not rely solely 
on self-reporting of DM or single CBG results, and we therefore 
believe that it is a more accurate representation of the true prevalence 
of diabetes and the degree of glycaemic control in these elective 
surgical patients.
Relation to other studies
The prevalence of DM in our study was higher than reported in 
non-surgical SA population studies. The International Diabetes 
Federation country-level DM estimates (5.4% for SA) were based 
on the weighted average of the scores of all data sources in the adult 
population.[1] The South African National Health and Nutrition 
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Examination Survey (SANHANES) utilised 
a multistage disproportionate, stratified 
cluster sampling approach to the general 
population based on census data, and 
demonstrated a 9.2% prevalence of DM 
(self-reported, and HbA1c ≥6.5%) in the 
adult population.[3] The prevalence of DM 
increases with age, and the higher mean 
age of our study population than that of the 
general SA population probably contributes 
to the higher prevalence of DM reported.[14]
Studies of surgical patients report a higher 
prevalence of DM than in the population 
overall. The South African Surgical 
Outcomes Study reported an SA national 
prevalence of self-reported DM of 10.1%.[10] 
This figure is considerably lower than ours. 
When investigating elective surgical patients 
in the Western Cape, Van der Spuy et al.[15] 
showed a prevalence of self-reported DM of 
16%, which is in keeping with our findings. 
However, neither of these studies evaluated 
the prevalence of undiagnosed DM at the 
time of surgery, or the degree of glycaemic 
control.
Using CBG and HbA1c levels as screening 
and diagnostic tools, our study identified a 
low prevalence of undiagnosed DM of 1.6% 
(5/310) in this surgical population. This is a 
considerably lower figure than that reported 
in a general population study by Bailey 
et al.,[16] which estimated a prevalence of 
undiagnosed DM (based on random CBG 
measurement) in the Western Cape of 12.7%. 
In 2012, Erasmus et al.[17] found a prevalence 
of undiagnosed DM (based on oral glucose 
tolerance tests and HbA1c) of 18.2% in 
adults in a community in Bellville, Western 
Cape. The reasons for the lower prevalence in 
our study probably include: (i) the stringent 
diagnostic criteria we applied; and (ii) the 
fact that all participants in our study had 
been assessed preoperatively by a number of 
healthcare practitioners.
Clinical implications
Our data suggest that DM screening for 
patients accessing elective surgery (often via 
primary healthcare) is well established in the 
studied healthcare services. Based on our 
findings, we suggest that screening for DM 
is not a priority in the preoperative period. 
This proposal is in keeping with conclusions 
from a systematic review that routine blood 
glucose or HbA1c levels are not needed 
in otherwise well non-diabetic patients 
presenting for general (non-orthopaedic or 
non-vascular) surgery.[18] However, cogni-
sance must be taken of the fact that a 
small number of patients do present with 
undiagnosed DM. The prevalence of DM and 
access to primary healthcare and hospitals 
are extremely variable in SA, and care must 
be taken in generalising our findings over 
too broad a population base.
Numerous studies have shown that poor 
preoperative glycaemic control is associated 
with increased complication rates in the 
perioperative period. These include increased 
length of stay,[4] an increased risk of failure of 
total ankle replacements,[5] increased infection 
rates in hip and knee arthroplasty,[6] and an 
increased risk of poor postoperative glycaemic 
control and postoperative complications.[7] 
In 2015, Kallio et al.[19] demonstrated that 
referral of poorly controlled diabetic patients 
(HbA1c >10%) to primary healthcare services 
for optimisation of glycaemic control before 
proceeding with total joint arthroplasty 
resulted in lower complication rates and 
shorter hospital stays.
The UK National Health Service Consen-
sus Guidelines of 2011,[20] endorsed by the 
Association of Anaesthetists of Great Britain 
and Ireland Working Party,[21] recommend 
postponing elective surgery in patients 
with an HbA1c level ≥8.5%, to allow for 
improved glycaemic control. In our study, 
47% of diabetic participants had an HbA1c 
exceeding this level. If these guidelines 
were to be adopted in the Western Cape, 
it is likely that a significant proportion of 
diabetic patients would have their surgery 
postponed.
Fig. 1. Study flow diagram. (HbA1c = glycated haemoglobin; CBG = capillary blood glucose.)
Consented
n=379
HbA1c result 
available
n=57
CBG result 
available
n=312
CBG <6.5 mmol/L
n=291
HbA1c result 
available
n=19
Total participants
N=391
Withheld consent
n=12
Known diabetic
n=61
Unknown
n=318
No HbA1c result
n=4
No CBG result
n=6
CBG ≥6.5 mmol/L
n=21
No HbA1c result 
available
n=2
Table 1. Participating hospitals
Hospital
Participants 
(N=379), n
Groote Schuur 176 
George 58
Paarl 42
New Somerset 40
Victoria 35
Mitchell’s Plain 28
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In our resource-limited environment, patients may experience long 
delays in accessing elective surgery. Last-minute postponement 
of surgery to allow for improved glycaemic control may not be 
practical. If poor control is identified timeously, the long waiting 
period presents an opportunity for optimisation of treatment without 
increasing the delay before surgery. Limited access to good-quality 
diabetes care is a major concern: an analysis of data from the 
SANHANES study estimated that only 19.4% of patients with DM in 
SA are both identified and well controlled,[22] which is in keeping with 
our findings, where only 24.6% of patients known to have DM had 
good control (HbA1c ≤7%).
As a secondary outcome, compliance was assessed using the 
MMAS-4. Only one of every five participants was noted to be non-
compliant, which is similar to the prevalence of self-reported non-
compliance with DM medication of 30% in Limpopo Province. [23] 
In our study, no conclusions could be drawn with regard to the 
correlation between compliance and glycaemic control. Verbal 
questionnaires to establish compliance have limited reliability. We 
used the MMAS-4 because this tool has been described as nearest 
to the gold standard.[24] Despite the reported compliance rate of 
80% in our study population, 47.4% of the diabetic participants 
were found to be poorly controlled, with an HbA1c level of 
≥8.5%. Interpreting the reasons for the disparity between reported 
medication compliance and glycaemic control is complex. Factors 
contributing to glycaemic control may include the prescribing and 
availability of correct medication, as well as lifestyle factors such as 
exercise and diet.
Study limitations
This study has some limitations. A smaller number of patients was 
recruited than we expected (379 v. 500) owing to the withdrawal 
of one of the hospitals initially planned to be an active site. This 
minimally increased the 95% CI associated with estimation of the 
prevalence of diabetes in this population from 5.3 to 8.
Nil per os guidelines followed in the participating hospitals 
were a minimum of 6 hours for solid food and 2 hours for clear 
fluids. In practice, most patients had longer nil per os times than 
this minimum requirement. The SEMDSA guidelines state that 
‘fasting is defined as no caloric intake for at least eight hours’.[13] 
It is possible that participants may have had oral or intravenous 
glucose containing fluids within 8 hours preoperatively, which may 
have affected the CBG result. Fasting status would not affect HbA1c 
results. Since HbA1c was used as a defining result for DM, we are 
confident that we did not overestimate the prevalence of DM in our 
study population.
The SEMDSA guidelines advise that bedside tests (glucose and 
HbA1c) should not be used to diagnose DM unless laboratory-based 
tests are unavailable.[13] For reasons of clinical convenience, and to 
make our study practicable, we used finger-prick CBG levels. We 
conducted laboratory HbA1c testing as a defining result to diagnose 
DM. The SEMDSA guidelines also state that ‘if only one of these tests 
is abnormal, a second abnormal result of the same testing method 
is required to confirm the diagnosis of diabetes on a different day, 
preferably within two weeks’.[13] Fourteen of our participants had a 
raised CBG level, with an HbA1c level <6.5%, and were not followed 
Table 2. Characteristics of the study population*
Patients (N=371) Diabetic (N=66, 17.8%) Non-diabetic (N=305, 82.2%) p-value
Age (years), mean (SD) 50.6 (16.5) 60.0 (11.9) 48.6 (16.7) <0.001
Male gender, n/N (%) 133/371 (36.4) 22/66 (33.3) 113/305 0.672
Major surgery, n/N (%) 40/371 (10.8) 5/66 (7.6) 35/305 (11.5) 0.511
ASA classification, n/N (%) <0.001
ASA 1 90/368 (24.5) 0/65 (0) 90/303 (29.7)
ASA 2 193/368 (52.4) 32/65 (49.2) 161/303 (53.1)
ASA 3 80/368 (21.7) 29/65 (44.6) 51/303 (16.8)
ASA 4 5/368 (1.4) 4/65 (6.2) 1/303 (0.3)
Co-morbid conditions, n/N (%)
Smoker 128/367 (34.9) 16/66 (24.2) 112/301 (37.2) 0.047
History of coronary artery disease 17/371 (4.6) 7/66 (10.6) 10/305 (3.3) 0.018
History of congestive heart failure 5/371 (1.3) 3/66 (4.5) 2/305 (0.7) 0.041
Stroke/TIA 15/371 (4.0) 8/66 (12.1) 7/305 (2.3) 0.002
Chronic renal disease 18/371 (4.9) 7/66 (10.6) 11/305 (3.6) 0.026
Peripheral arterial disease 3/371 (0.8) 2/66 (3.0) 1/305 (0.3) 0.083
Hypertension 165/371 (44.5) 55/66 (83.3) 110/305 (36.1) <0.001
Advanced retinopathy 13/371 (3.5) 13/66 (19.7) 0/305 (0) <0.001
Functional status, n/N (%) <0.001
Totally independent 324/370 (87.6) 46/66 (69.7) 278/304 (91.4)
Partially dependent 39/370 (10.5) 19/66 (28.8) 20/304 (6.6)
Totally dependent 7/370 (1.9) 1/66 (1.5) 6/304 (2.0)
SD = standard deviation; ASA = American Society of Anesthesiologists physical status classification system; TIA = transient ischaemic attack.
*Denominators vary, as patients with missing data were excluded.
Table 3. Glycaemic control of known diabetics based on HbA1c results
HbA1c ≤7%  HbA1c 7.1 - 8.4% HbA1c ≥8.5%
Known diabetics, n (%; 95% CI) 14 (24.6; 13.4 - 35.8) 16 (28.1; 16.4 - 39.7) 27 (47.4; 34.4 - 60.3)
HbA1c = glycated haemoglobin; CI = confidence interval.
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up. Our results may therefore underestimate the prevalence of 
undiagnosed diabetes in this surgical population.
Suggested further research
This study provides an objective assessment of the prevalence and 
glycaemic control of DM in the perioperative patient population in the 
Western Cape, SA. The poor control of DM in the perioperative period 
suggests that further research is needed to evaluate perioperative 
complication rates in these patients. Interventions to improve long-
term glycaemic control should be identified in elective surgical 
patients, and the effects of their introduction should be studied.
Conclusions
DM is a common disease that is associated with increased peri-
operative complications. It was well diagnosed but poorly managed 
in our study population. We recommend that early identification of 
poorly managed DM (by HbA1c measurement) should be prioritised 
in elective surgical patients. Doing this could result in timeous 
referral to the appropriate services for improvement of glycaemic 
control before surgery, and in turn allow time for improvement 
of preoperative management of DM, without causing a significant 
increase in surgical waiting times. Overall, the goal would be lower 
perioperative complication rates.
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